RCOphth invited to address issues of capacity at a meeting of the All Party Parliamentary Group for Eye Health and Visual Impairment.
Miss Corbett commented, ‘The demand on eye services has increased by 30% over the last five years in the UK. This is largely due to an ageing population with the associated chronic diseases such as glaucoma, age related macular degeneration (AMD) and diabetes.’
TREATMENT OF AGE-RELATED MACULAR DEGENERATION BY INTRAVITREAL INJECTION WITH RANIZUMAB (LUCENTIS):Treatment leaflet and Patient Consent form
This leaflet provides information about the eye condition wet age-related macular degeneration (AMD).
Use of Avastin (bevacizumab) in age related macular degeneration
College statement on the use of Avastin (bevacizumab) in age related macular degeneration December 2014
Management algorithm for age-related macular degeneration – AMD Guidelines 2013
Management algorithm for age-related macular degeneration : annex to AMD guidelines 2013
Joint RCOphth and Macular Society Report on Macular Services Survey 2014
In September 2013 and again in August 2014 the Royal College of Ophthalmologists and the Macular Society undertook a survey of Consultant Ophthalmologists with sub-speciality interest in medical retinal disorders. The survey sought their opinions on the current state of medical retinal services in the UK, this report summarises the report findings.